Home › Trial NCT04714086
Expanded Access Program for Avapritinib
- Trial IDNCT04714086
- StatusUnknown
- PhaseN/A
- Study typeExpanded_Access
- SponsorBlueprint Medicines Corporation
- Enrollment—
- Start date—
- ConditionsSolid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.